Tirzepatide 70mg*10vials

描述

Core Features
$\ge 99.0\%$ Purity & High-Capacity Batch Consistency: Produced using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Tirzepatide features a 39-amino-acid chain and a complex $\text{C}_{20}$ fatty diacid side chain; the 70mg fill volume per vial imposes rigorous demands on the purification process. Utilizing precise industrial-grade reversed-phase preparative HPLC (RP-HPLC), we strictly eliminate truncated sequences and non-specific by-products. Each 70mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for your large-scale in vitro and long-term in vivo studies.
Synergistic Dual-Target Mechanism: As an innovative dual-incretin agonist, Tirzepatide binds to both GIPR and GLP-1R with extremely high affinity. This unique, integrated dual-agonist action enables: GIPR-mediated metabolic remodeling (improving adipose tissue storage capacity and enhancing systemic insulin sensitivity) and GLP-1R-mediated glycemic control (regulating glucose-dependent insulin release while effectively improving satiety and energy balance).
Advanced Cryo-Lyophilization Process: The 70mg high-concentration peptide powder undergoes moisture sublimation at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process ensures that the peptide’s spatial secondary structure remains “locked” in a stable state during prolonged storage, significantly enhancing biological activity stability upon reconstitution.

🛠️ Technical Specifications & Parameters
Product Specification: 70 mg / Vacuum-Sealed Glass Vial
Molecular Formula: $\text{C}_{225}\text{H}_{348}\text{N}_{48}\text{O}_{68}$
Appearance: White to off-white sterile lyophilized powder / intact solid cake
Validation: Supplied with original manufacturer HPLC purity chromatograms and MS molecular weight verification reports.

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be immediately stored in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions that ensure protection from light and moisture, alongside a high-vacuum seal. Given the large 70mg fill volume and the product’s susceptibility to degradation post-reconstitution, researchers are strongly advised to aliquot the material into single-experiment doses within a laminar flow hood and freeze them; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: The 70mg Tirzepatide is shipped via express service using high-density, five-layer insulated foam boxes combined with high-capacity phase-change gel packs. This ensures the peptide’s higher-order spatial conformation remains “locked” in a stable, frozen state while traversing diverse global climate zones.

📝 Research Compliance & Disclaimer
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Tirzepatide 70mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, its use is limited to academic research within university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., cell receptor binding affinity assays, high-throughput drug screening, long-term metabolic cohort monitoring in large animal models). Any non-compliant use—including human clinical injection, oral administration, substitution for prescribed medication, or use as an illicit weight-loss agent, performance-enhancing drug, or stimulant—is strictly prohibited. This platform enforces rigorous multi-level verification of the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.